Related Experiment Video
Updated: Sep 28, 2025
07:57
A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
21.2K
Carnitine and Depression
Ting Liu1,2, Kunhong Deng3, Ying Xue1,2
1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Frontiers in Nutrition
|April 4, 2022
Summary
Acylcarnitines (ACs) show altered levels in depression patients, suggesting their potential as diagnostic biomarkers. Acetyl-L-carnitine supplementation may also offer new therapeutic strategies for depression.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Depression is a prevalent global mental health issue with insufficient understanding of its pathogenesis and treatment.
- Carnitine, a naturally occurring substance, plays roles in various biological processes and has been linked to mental health conditions.
- Previous research indicates altered acylcarnitine (ACs) levels in depressed individuals and potential benefits from acetyl-L-carnitine supplementation.
Purpose of the Study:
- To review the role of acylcarnitines (ACs) in patients with depression.
- To investigate the potential of ACs as diagnostic biomarkers for depression.
- To explore novel therapeutic approaches for depression based on ACs.
Main Methods:
- Literature review of studies investigating carnitine and its derivatives in depression.
- Analysis of research on acylcarnitine levels in depressed patients versus controls.
- Examination of studies on the therapeutic effects of acetyl-L-carnitine in depression.
Main Results:
- Significant alterations in acylcarnitine (AC) levels are observed in individuals with depression compared to healthy controls.
- Acetyl-L-carnitine supplementation has demonstrated positive effects in the treatment of depression.
- ACs show promise as potential biomarkers for depression diagnosis.
Conclusions:
- Acylcarnitines (ACs) are implicated in the pathophysiology of depression.
- ACs may serve as valuable biomarkers for the diagnosis of depression.
- Targeting carnitine metabolism could offer new avenues for depression treatment.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
213
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
22.8K
Related Concept Videos
01:18Depression: Overview
399
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
399
01:03Long-term Depression
2.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.7K
01:27Depressive Disorders: Etiology
176
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
176
01:21G-protein Coupled Receptors
122.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
122.1K
01:27Depressive Disorders: MDD and Dysthymia
231
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
231
01:25Antidepressant Drugs: Overview
841
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
841